Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 217.20M | £ 519.00M | £ 885.00M | £ 2.67B | £ 2.89B |
Total Assets | £ 5.19B | £ 5.33B | £ 5.60B | £ 6.42B | £ 6.57B |
Total Debt | £ 3.11B | £ 3.19B | £ 3.43B | £ 2.85B | £ 3.03B |
Net Debt | £ 2.89B | £ 2.67B | £ 2.54B | £ 186.50M | £ 139.10M |
Total Liabilities | £ 4.01B | £ 4.06B | £ 4.32B | £ 3.44B | £ 3.64B |
Stockholders Equity | £ 1.19B | £ 1.27B | £ 1.28B | £ 2.98B | £ 2.93B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |